CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $247,000 | -19.5% | 110,614 | -10.2% | 0.25% | -11.5% |
Q2 2022 | $307,000 | -43.5% | 123,148 | +10.7% | 0.28% | -25.1% |
Q1 2022 | $543,000 | -23.0% | 111,259 | +78.6% | 0.37% | -19.9% |
Q4 2021 | $705,000 | -6.5% | 62,295 | +20.3% | 0.46% | -3.5% |
Q3 2021 | $754,000 | +34.9% | 51,766 | +8.0% | 0.48% | +34.5% |
Q2 2021 | $559,000 | +7.3% | 47,953 | +12.3% | 0.36% | +1.1% |
Q1 2021 | $521,000 | -25.7% | 42,702 | -23.8% | 0.35% | -24.2% |
Q4 2020 | $701,000 | – | 56,035 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |